Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13694 | 756 | 52.4 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2997 | 2104 | FENCAMFAMINE//N ACETYL ASPARTATE//N ACETYLASPARTATE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | N ACETYL ASPARTATE | Author keyword | 12 | 21% | 6% | 49 |
2 | N ACETYLASPARTATE | Author keyword | 7 | 12% | 7% | 52 |
3 | MOL DYNAM MENTAL DISORDERS | Address | 6 | 18% | 4% | 29 |
4 | PROTON MAGNETIC RESONANCE SPECTROSCOPY | Author keyword | 5 | 10% | 7% | 50 |
5 | VISN MENTAL ILLNESS EDUC CLIN MIRECC 19 | Address | 4 | 67% | 1% | 4 |
6 | CHOLINE CONTAINING COMPOUNDS | Author keyword | 3 | 32% | 1% | 9 |
7 | NDUFV2 | Author keyword | 3 | 57% | 1% | 4 |
8 | E KANTO MED | Address | 3 | 100% | 0% | 3 |
9 | PROJECT IZOPHRENIA AFFECT DISORDERS | Address | 2 | 67% | 0% | 2 |
10 | HOSP UNIV PSIQUIATR PERE MATA | Address | 2 | 50% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | N ACETYL ASPARTATE | 25 | 22% | 13% | 99 |
2 | BRAIN PHOSPHORUS METABOLISM | 23 | 64% | 3% | 23 |
3 | ANTERIOR CINGULATE REGION | 20 | 100% | 1% | 9 |
4 | SUBUNIT GENE NDUFV2 | 17 | 72% | 2% | 13 |
5 | ACETYL ASPARTATE LEVELS | 8 | 70% | 1% | 7 |
6 | CHOLINE CONTAINING COMPOUNDS | 7 | 46% | 2% | 12 |
7 | HIPPOCAMPAL H 1 MRS | 6 | 80% | 1% | 4 |
8 | POTENTIAL PERIPHERAL MARKER | 6 | 80% | 1% | 4 |
9 | ACETYLASPARTATE | 6 | 19% | 4% | 30 |
10 | PROTON MRS | 6 | 18% | 4% | 32 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Glutamatergic abnormalities in schizophrenia: A review of proton MRS findings | 2014 | 23 | 70 | 74% |
Neurometabolites in schizophrenia and bipolar disorder - A systematic review and meta-analysis | 2012 | 33 | 160 | 82% |
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery | 2014 | 22 | 128 | 30% |
Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia-A Systematic Review and Meta-Analysis | 2011 | 43 | 119 | 74% |
Impaired mitochondrial function in psychiatric disorders | 2012 | 80 | 164 | 31% |
Mitochondrial dysfunction in schizophrenia: an evolutionary perspective | 2015 | 2 | 73 | 33% |
Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia | 2011 | 85 | 175 | 35% |
Measurement of brain metabolites by H-1 magnetic resonance spectroscopy in patients with review and meta-analysis | 2005 | 146 | 104 | 67% |
Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings | 2006 | 102 | 42 | 64% |
Mitochondrial involvement in psychiatric disorders | 2008 | 104 | 93 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL DYNAM MENTAL DISORDERS | 6 | 18% | 3.8% | 29 |
2 | VISN MENTAL ILLNESS EDUC CLIN MIRECC 19 | 4 | 67% | 0.5% | 4 |
3 | E KANTO MED | 3 | 100% | 0.4% | 3 |
4 | PROJECT IZOPHRENIA AFFECT DISORDERS | 2 | 67% | 0.3% | 2 |
5 | HOSP UNIV PSIQUIATR PERE MATA | 2 | 50% | 0.4% | 3 |
6 | MULTIMODAL NEUROIMAGING IZOPHRENIA GRP | 2 | 50% | 0.4% | 3 |
7 | SHERVERT FRAZIER | 2 | 36% | 0.5% | 4 |
8 | MR ADV PLICAT | 1 | 38% | 0.4% | 3 |
9 | PL PSYCHOL MED | 1 | 100% | 0.3% | 2 |
10 | POLYCLIN NEURON | 1 | 100% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000215072 | NESS FDN//HIGHLAND PSYCHIAT FDN//IMAGING SCI MRI UNIT |
2 | 0.0000173547 | MAGNETIC RESONANCE SPECTROSCOPY//SPECTROSCOPIC IMAGING//LCMODEL |
3 | 0.0000136462 | KETAMINE//EXPT THER EUT PATHOPHYSIOL BRANCH//INTEGRAT BIOMED BRAIN DIS |
4 | 0.0000125966 | PROGRAM STRUCT MOL NEUROSCI//STRUCT NEUROSCI//PERFORANT PATH DENTATE GYRUS PATHWAY |
5 | 0.0000123010 | BIPOLAR DISORDERS//EUTHYMIA//PEDIAT BRAIN INTERVENT |
6 | 0.0000113570 | PSYCHIATRY RESEARCH-NEUROIMAGING//PSYCHIAT NEUROIMAGING PSYCHIAT//GENETIC HIGH RISK |
7 | 0.0000100940 | ISPOT D//TREATMENT DEP S DISORDERS//SECT NEUROIMAGING MOOD ANXIETY DISORDERS |
8 | 0.0000097744 | INOSITOL MONOPHOSPHATASE//INOSITOL//INOSITOL DEPLETION |
9 | 0.0000095025 | LITHIUM RATIO//GENOKEY S//SCIONDTU |
10 | 0.0000081708 | META NISOLDIPINE//VOLTAGE ACTIVATED//M NISOLDIPINE |